Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amylin Pharmaceuticals LLC    AMLN

SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsSector newsTweets 

Amylin Pharmaceuticals, Inc. : Amylin Pharmaceuticals to Webcast First Quarter Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 10:20pm CEST

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the first quarter of 2012 on Thursday, April 26, 2012 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. On the same date pre-market, Amylin will release financial results for the first quarter of 2012.

The call will be webcast live through the "Investors" section of Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com approximately 15 minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (888) 989-4344 (U.S./Canada) or (312) 470-7140 (international), participant passcode number 7994841. A replay of the call will also be available by phone beginning approximately two hours after the close of the call and can be accessed at (800) 756-0205 (U.S./Canada) or (203) 369-3002 (international).

About Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin is committed to delivering novel therapies that transform the way diabetes and other metabolic disorders are treated. Amylin is headquartered in San Diego, Calif. and has a commercial manufacturing facility in Ohio. More information on Amylin Pharmaceuticals is available at www.amylin.com.

Amylin Pharmaceuticals, Inc.
Investors
Christine Everett-Zedelmayer
858-458-8517
[email protected]
or
Media
Alice Izzo
858-642-7272
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AMYLIN PHARMACEUTICALS LLC
2012 AMYLIN PHARMACEUTICALS, INC. : Bristol-Myers Squibb and AstraZeneca Complete Exp..
2012DJEli Lilly To Record $1.26 Billion Benefit from Amylin
2012DJASTRAZENECA : Bristol-Myers Squibb Completes Purchase of Amylin
2012DJBristol-Myers Executive Charged With Insider Trading
2012DJBristol-Myers Executive Charged With Insider Trading
2012DJBristol-Myers Executive Charged With Insider Trading
2012 Bristol-Myers executive charged with insider trading
2012DJU.S. Charges Bristol-Myers Executive With Insider Trading
2012DJBristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider..
2012DJCARL ICAHN : Icahn Sounds the Alarm on Forest Labs
More news
Sector news : Biopharmaceuticals
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJASTRAZENECA : in Pact with Recordati for Heart-Drug Seloken in Europe
05/19 European shares claw back gains after worst week in six months
05/19 FTSE climbs for fourth straight week, shrugging off Trump slump
05/19 Hikma trims full year revenue forecast on Advair U.S. launch delay
More sector news : Biopharmaceuticals
Advertisement
Sector and Competitors
1st jan.Capitalization (M$)
AMYLIN PHARMACEUTICALS..0.00%0
BIOGEN INC-4.30%53 048
CSL LIMITED30.52%44 146
ALEXION PHARMACEUTICAL..-6.96%25 564
GRIFOLS SA33.77%17 681
BIOMARIN PHARMACEUTICA..7.71%15 570
More Results